Literature DB >> 11522865

Dialysis improves endothelial function in humans.

J M Cross1, A Donald, P J Vallance, J E Deanfield, R G Woolfson, R J MacAllister.   

Abstract

BACKGROUND: Circulating inhibitors of endothelial function have been implicated in the pathogenesis of vascular disease in chronic renal failure. The aim of this study was to determine if lowering the plasma concentration of these and other dialysable toxins improves endothelial function. To do this we compared the acute effects on endothelial function of single episodes of haemodialysis with automated peritoneal dialysis. We hypothesized that endothelial function would improve after dialysis, with a greater effect seen after haemodialysis due to more substantial clearance of endothelial toxins per-treatment.
METHODS: Subjects with end-stage renal failure undergoing haemodialysis (n=16) or automated peritoneal dialysis (n=14) were investigated. Endothelial function was determined using vascular ultrasound to measure flow-mediated dilatation of the brachial artery and was compared with the dilatation caused by sublingual glyceryl trinitrate. Endothelial function was assessed before and after a single dialysis treatment. Plasma concentrations of the inhibitors of endothelial function, asymmetric dimethyl-l-arginine and homocysteine were measured. Flow-mediated dilatation was expressed as percentage change from basal diameter and analysed using Student's t test.
RESULTS: The plasma concentration of circulating inhibitors of endothelial function was reduced after haemodialysis but not peritoneal dialysis. Haemodialysis increased flow-mediated dilatation from 4.0+/-1.0% to 5.8+/-1.2% (P<0.002). These changes persisted for 5 h but returned to baseline by 24 h. Automated peritoneal dialysis had no acute effect on flow-mediated dilatation (5.9+/-1.1% vs 5.4+/-0.8% after, P>0.5). There were no effects of either dialysis modality on dilatation to glyceryl trinitrate.
CONCLUSIONS: Short-term reduction of circulating inhibitors of endothelial function by haemodialysis is associated with increased flow-mediated dilatation. These data suggest that dialysable endothelial toxins have deleterious effects on endothelial function that are rapidly reversible.

Entities:  

Mesh:

Year:  2001        PMID: 11522865     DOI: 10.1093/ndt/16.9.1823

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  14 in total

Review 1.  Improved blood pressure control with nocturnal hemodialysis: review of clinical observations and physiologic mechanisms.

Authors:  Brendan B McCormick; Christopher T Chan
Journal:  Curr Hypertens Rep       Date:  2004-04       Impact factor: 5.369

2.  Changes in pulse pressure during hemodialysis treatment and survival in maintenance dialysis patients.

Authors:  Paungpaga Lertdumrongluk; Elani Streja; Connie M Rhee; John J Sim; Daniel Gillen; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Clin J Am Soc Nephrol       Date:  2015-06-01       Impact factor: 8.237

3.  Associations of endothelial dysfunction and arterial stiffness with intradialytic hypotension and hypertension.

Authors:  Ruth Dubin; Christopher Owens; Warren Gasper; Peter Ganz; Kirsten Johansen
Journal:  Hemodial Int       Date:  2011-06-09       Impact factor: 1.812

4.  Alteration of serum semicarbazide-sensitive amine oxidase activity in chronic renal failure.

Authors:  J Nemcsik; E Szökö; Zs Soltész; E Fodor; L Toth; J Egresits; T Tábi; K Magyar; I Kiss
Journal:  J Neural Transm (Vienna)       Date:  2007-04-13       Impact factor: 3.575

5.  Hemodialysis acutely impairs endothelial function in children.

Authors:  Marc R Lilien; Hein A Koomans; Cornelis H Schröder
Journal:  Pediatr Nephrol       Date:  2004-12-31       Impact factor: 3.714

6.  ADMA injures the glomerular filtration barrier: role of nitric oxide and superoxide.

Authors:  Mukut Sharma; Zongmin Zhou; Hiroto Miura; Andreas Papapetropoulos; Ellen T McCarthy; Ram Sharma; Virginia J Savin; Elias A Lianos
Journal:  Am J Physiol Renal Physiol       Date:  2009-03-18

Review 7.  Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and the development of renal injury in chronic kidney disease.

Authors:  Seiji Ueda; Sho-Ichi Yamagishi; Yuriko Matsumoto; Kei Fukami; Seiya Okuda
Journal:  Clin Exp Nephrol       Date:  2007-06-28       Impact factor: 2.801

Review 8.  Asymmetrical dimethylarginine in renal disease: limits of variation or variation limits? A systematic review.

Authors:  Johannes Jacobi; Philip S Tsao
Journal:  Am J Nephrol       Date:  2007-10-24       Impact factor: 3.754

9.  Doppler assessment of brachial artery flow as a measure of endothelial dysfunction in pediatric chronic renal failure.

Authors:  Gehan Hussein; Yasser Bughdady; Manal E Kandil; Hafez M Bazaraa; Heba Taher
Journal:  Pediatr Nephrol       Date:  2008-06-10       Impact factor: 3.714

Review 10.  Protein-energy wasting and mortality in chronic kidney disease.

Authors:  Alice Bonanni; Irene Mannucci; Daniela Verzola; Antonella Sofia; Stefano Saffioti; Ezio Gianetta; Giacomo Garibotto
Journal:  Int J Environ Res Public Health       Date:  2011-05-19       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.